Biomedical, Clinical & Life Sciences

PhRMA Foundation: 2025 Drug Delivery Postdoctoral Fellowship

No Applicants // Limit: 1 postdoctoral applicant per lab

The PhRMA Foundation Postdoctoral Fellowship in Drug Delivery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility
Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Delivery Postdoctoral Fellowship webpage.

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type

PhRMA Foundation: 2025 Drug Delivery Predoctoral Fellowship

Limit: 1 predoctoral applicant per lab

M.P. Resmi (Ganesh Lab, Department of Molecular Medicine) 

The PhRMA Foundation Predoctoral Fellowship in Drug Delivery provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility
Only one predoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Delivery Predoctoral Fellows webpage.

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type

PhRMA Foundation: 2025 Translational Medicine Predoctoral Fellowships

No Applicants // Limit: 1 predoctoral applicant per lab

The PhRMA Foundation’s Predoctoral Fellowship in Translational Medicine supports promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in translational medicine.

Eligibility
Only one predoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Translational Medicine Predoctoral Fellowship webpage.

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type

PhRMA Foundation: 2025 Translational Medicine Postdoctoral Fellowships

No Applicants // Limit: 1 postdoctoral applicant per lab

The PhRMA Foundation’s Postdoctoral Fellowship in Translational Medicine supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in translational medicine.

Eligibility
Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Postdoctoral Fellowships - Translational Medicine webpage.

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type

PhRMA Foundation: 2025 Drug Discovery Predoctoral Fellowship

Limit: 1 predoctoral applicant per lab

M. Ma (Hongmin Li Lab) 

The PhRMA Foundation Predoctoral Fellowship in Drug Discovery provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug discovery research.

Eligibility
Only one predoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Discovery Predoctoral Fellowship webpage

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type

Medical Scientist Training Program (MSTP) (T32) - May 2025 Deadline - PAR-24-128

The University of Arizona is ineligible to apply to this cycle due to an existing proposal.

Funding Type
Internal Deadline
External Deadline
5/25/2025

Nursing Workforce Diversity (NWD) Program

Limit: 1 // Tickets Available: 0 

J. Young (Nursing)

Eligibility

Eligible applicants may submit only one application to this NOFO. Multiple applications from any single organization are not allowed.


Purpose
The purpose of the Nursing Workforce Diversity (NWD) program is to increase nursing education opportunities for individuals who are from disadvantaged backgrounds (including racial and ethnic minorities underrepresented among registered nurses). The program uses comprehensive, evidence-based strategies to provide more inclusive and culturally aligned nursing education environments that will support students from disadvantaged backgrounds. Please refer to the Bureau of Health Workforce Glossary for program terms applicable to this Notice of Funding Opportunity (i.e., disadvantaged background, underrepresented minority).


 

Funding Type
Internal Deadline
External Deadline
3/18/2025

2026 Pew-Stewart Scholars Program for Cancer Research

Limit: 1 // Tickets Available: 1

Kenry (Pharmacology and Toxicology) 

The University of Arizona Cancer Center (UACC) can nominate one individual for the 2026 Pew-Stewart Scholars for Cancer Research program. For more information please contact: UACC-PreAward.

In line with The Stewart Trust’s mission to invest in innovative, cutting-edge cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from nominees conducting cancer research at NCI-designated cancer centers, or cancer-focused institutions. The Pew-Stewart Scholars Program for Cancer Research is distinct from the Pew Scholars Program, and it follows a different, but parallel set of guidelines and procedures for nominating an applicant whose research is related to cancer.

In early April 2025, a letter of invitation and application instructions will be sent to the leaders of the cancer research institutions selected to submit a nominee for the 2026 class. Centers are expected to complete a limited submission competition in order to identify and select one nominee. For guidance on this process, please contact Pew-Stewart@pewtrusts.org.

  • Center administration should distribute this invitation and award eligibility details to all investigators via an email announcement or website posting.
  • Interested applicants should submit pre-proposal material to an internal selection committee for consideration.
  • To nominate a candidate, a member of the internal selection committee must complete an online survey from the Pew program office describing the selection process used by the institution and submit the name and contact information of the chosen applicant by May 14, 2025.
  • Nominations of applicants to the program will not be considered after May 14, 2025.
  • The Pew program office will email grant application portal login information and a detailed application guide directly to all nominated applicants by June 11, 2025. The online application website will open on June 11, 2025.
  • For research administrators assisting an applicant, please send an email with your grant applicant cc’ed to Pew-Stewart@pewtrusts.org after June 11, 2025, to receive access to the portal. No requests will be accepted prior to this date.
  • The application submission deadline is Aug. 27, 2025.
  • Every application will be reviewed by the program's National Advisory Committee. The committee will make recommendations to the board of directors of The Pew Charitable Trusts in April 2026. Candidates will be notified in April if they have been recommended to the Stewart and Pew boards.
  • A public announcement of the award will be made in June. Grant agreements will be issued to the grant hosting institution of each scholar in August of the award year.
Funding Type
Internal Deadline
External Deadline
5/14/2025 (Nomination)
Solicitation Type

V Foundation Adult Translational Cancer Research Award 2025

No Applicants // Limit: 2 (1 Translational nominee, 1 All-Star Translational nominee) // Tickets Available: 2 

The University of Arizona Cancer Center (UACC) can nominate up to two proposals: one Translational nominee and one All-Star Translational nominee (if eligible) for the V Foundation Adult Translational Cancer Research Award 2025. 

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the Translational Adult Cancer Research Grant which advances basic laboratory discoveries towards clinical use, ultimately improving human health and is restricted to adult cancer research.

This Translational grant is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Research on ANY adult cancer type can be funded. Applicants may propose cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to test hypotheses, develop biomarkers, or mechanisms. The research must apply in a direct way to human beings within 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Funding Type
Internal Deadline
External Deadline
3/18/2025

Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS)

Limit: 1 per SIP

K. Ellingson (Public Health) for SIP25-005 Understanding the potential of early childcare and education (ECE) centers in promoting childhood vaccines and RSV prevention products

S. Carvajal (College of Public Health's Prevention Research Center) for SIP25-006 Overdose Prevention and Treatment Research Network (OPTRN)

Eligibility: 
Only one application per SIP per institution is allowed (e.g., multiple applications for the same SIP (listed in Section VIII) from the same institution are NOT permitted).

Purpose:
This Notice of Funding Opportunity (NOFO) invites applications from CDC Health Promotion and Disease Prevention Research Centers (PRCs), selected for funding under RFA-DP-24-004, to apply for supplemental funding to conduct Special Interest Research Projects (SIPs) to inform public health practice. PRCs will conduct high-quality applied health promotion and disease prevention research projects in real-world settings to identify, design, test, evaluate, disseminate, and translate interventions (i.e., programs, practices, policies, or strategies) to prevent and reduce risk for the leading causes of illness, disability, and death in the United States.

Funding Type
Internal Deadline
External Deadline
2/28/2025